Cantor Fitzgerald lowered the firm’s price target on Ryan Specialty (RYAN) to $52 from $63 and keeps a Neutral rating on the shares. The initial positive stance on insurance brokers appears premature and overly optimistic, as near-term fundamentals are likely to deteriorate before improving. While the subgroup remains interesting, negative consensus organic growth revisions are expected in the interim.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $60 from $61 at Mizuho
- Ryan Specialty price target raised to $63 from $61 at Wells Fargo
- Ryan Specialty price target lowered to $58 from $65 at Barclays
- Ryan Specialty price target lowered to $61 from $65 at Goldman Sachs
- Ryan Specialty price target lowered to $56 from $63 at JPMorgan
